Bloomage BioTechnology Corporation Limited (SHA:688363)

SHA:688363 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	776.6	719.27	1,169	1,606	1,807	1,390
Trading Asset Securities	-	30.02	140.04	530.72	846.89	722.7
Cash & Short-Term Investments	776.6	749.29	1,309	2,137	2,654	2,113
Cash Growth	12.89%	-42.75%	-38.75%	-19.47%	25.58%	-29.62%
Accounts Receivable	567.93	547.38	450.19	457.87	402.22	388.99
Other Receivables	40.64	45.27	39.42	51.91	28.9	34.7
Receivables	608.57	592.65	489.61	509.78	431.12	423.69
Inventory	1,168	1,248	1,135	1,162	709.13	476.77
Other Current Assets	165.34	150.96	189.99	214.93	190.37	650.11
Total Current Assets	2,719	2,741	3,123	4,023	3,984	3,664
Property, Plant & Equipment	4,069	4,203	3,657	2,913	2,305	1,258
Long-Term Investments	594.21	585.02	502.99	592.63	400.32	17.9
Goodwill	182.24	174.09	251.28	247.22	67.15	74.64
Other Intangible Assets	504.45	490.63	496.97	475.06	467.26	426.74
Long-Term Deferred Tax Assets	339.85	355.56	336.98	302.59	246.11	93
Long-Term Deferred Charges	106.65	100.34	98.14	116.43	31.85	15.64
Other Long-Term Assets	57.65	7.51	3.63	11.5	1.44	167.32
Total Assets	8,573	8,657	8,470	8,682	7,504	5,717
Accounts Payable	161.11	195.41	186.78	247.75	243.55	119.08
Accrued Expenses	351.42	587.09	479.49	672.75	704.09	236.64
Short-Term Debt	-	49.92	-	139.2	-	24.08
Current Portion of Long-Term Debt	52.02	28.89	106.08	36.54	36.46	-
Current Portion of Leases	53.66	62.79	47.05	53.67	49.61	-
Current Income Taxes Payable	11.91	13.85	55.68	76.43	135.52	50.91
Current Unearned Revenue	82.45	63.48	55.58	67.74	50.83	43.4
Other Current Liabilities	413.83	339.6	290.13	349.97	180.46	78.77
Total Current Liabilities	1,126	1,341	1,221	1,644	1,401	552.87
Long-Term Debt	82.11	65.12	2.32	107.97	144.18	-
Long-Term Leases	45.92	152.97	52.66	52.42	69.77	-
Long-Term Unearned Revenue	249.01	253.24	205.73	188.68	182.71	141.35
Long-Term Deferred Tax Liabilities	4.36	4.57	5.09	5.66	4.12	4.54
Total Liabilities	1,508	1,817	1,487	1,999	1,801	698.76
Common Stock	481.68	481.68	481.68	481.09	480	480
Additional Paid-In Capital	3,856	3,853	3,841	3,753	3,569	3,452
Retained Earnings	2,868	2,700	2,708	2,409	1,674	1,088
Treasury Stock	-219.95	-219.95	-105.88	-	-	-
Comprehensive Income & Other	46.82	-4.32	19.57	-9.1	-23.91	-0.01
Total Common Equity	7,033	6,810	6,944	6,634	5,699	5,020
Minority Interest	32.1	29.63	39.33	49.21	3.45	-1.62
Shareholders' Equity	7,065	6,840	6,983	6,683	5,702	5,018
Total Liabilities & Equity	8,573	8,657	8,470	8,682	7,504	5,717
Total Debt	233.7	359.69	208.1	389.79	300.01	24.08
Net Cash (Debt)	542.9	389.6	1,101	1,747	2,354	2,089
Net Cash Growth	13.42%	-64.60%	-37.00%	-25.77%	12.67%	-30.42%
Net Cash Per Share	1.12	0.80	2.28	3.62	4.87	4.37
Filing Date Shares Outstanding	478.36	478.36	480.26	481.09	480	480
Total Common Shares Outstanding	478.36	478.36	480.26	481.09	480	480
Working Capital	1,592	1,400	1,902	2,379	2,584	3,111
Book Value Per Share	14.70	14.24	14.46	13.79	11.87	10.46
Tangible Book Value	6,346	6,145	6,196	5,911	5,165	4,518
Tangible Book Value Per Share	13.27	12.85	12.90	12.29	10.76	9.41
Buildings	2,466	2,496	1,756	1,385	1,269	458.14
Machinery	2,096	1,794	1,410	1,148	812.35	495.06
Construction In Progress	443.01	640.98	1,109	830.45	516.72	618.11

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.